United States· US:0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821
ELELYSO
A taliglucerase alfa product containing taliglucerase alfa, registered in United States by Pfizer Laboratories Div Pfizer Inc. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Taliglucerase alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC A16AB11 (taliglucerase alfa), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Taliglucerase alfa · ATC A16AB11
2 / 19 countries
- Canada
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TALIGLUCERASE ALFA
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Country
- United States (US)
- ATC code
- A16AB11
- ATC class
- Taliglucerase alfa
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1100690106011 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS
- ndc110069-0106-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Taliglucerase alfa in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4928203c-2193-4128-912b-5324f6fd9ab9 GET /v1/drugs/4928203c-2193-4128-912b-5324f6fd9ab9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "200",
"substance": "TALIGLUCERASE ALFA",
"productndc": "0069-0106",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "U/5mL",
"application_number": "BLA022458",
"marketing_category": "BLA"
}See everything about taliglucerase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.